Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,318 INR | -1.33% | -2.93% | -10.06% |
Apr. 26 | Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer, Effective May 9, 2024 | CI |
Mar. 18 | Dr Lal Pathlabs Names CEO | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analyst opinion has improved significantly over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With an expected P/E ratio at 54.25 and 46.64 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.06% | 2.31B | B- | ||
-18.58% | 8.3B | B+ | ||
+47.25% | 3.78B | C+ | ||
-8.58% | 2.47B | - | ||
-38.71% | 2.46B | B- | ||
-5.44% | 1.95B | C- | ||
-17.79% | 1.59B | A- | ||
-40.78% | 1.21B | C+ | ||
+6.69% | 1.1B | B+ | ||
-23.31% | 931M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LALPATHLAB Stock
- Ratings Dr. Lal PathLabs Limited